Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End Use Industry, Health/Functional Positioning, Distribution Channel, and Region – Global Forecast to 2031
The precision biotics market is estimated to record USD 4.91 billion in 2026 and reach USD 9.26 billion by 2031, at a CAGR of 13.5% from 2026 to 2031.
“Gut & brain segment is driving market growth due to the rising focus on the gut-brain axis and personalized mental wellness solutions”
The gut & brain sub-segment under health/functional positioning is expected to witness the fastest growth in the precision biotics market owing to the growing awareness about the gut-brain axis and rising cases of stress, anxiety, depression, and other mental conditions. The ongoing developments in microbiome science, growing scientific evidence of the impact of gut microbiota on brain function, and the need for tailored solutions for improving mental wellness are leading to the rising use of precision biotics for gut and brain health.
“E-commerce is driving market growth through expanding online retail and digital health platforms”
E-commerce is expected to become the fastest-growing route for distribution within the precision biotics market owing to the rising online purchasing trends and consumers' growing inclination toward easily available precision biotics products online. The development of online pharmacies, health and wellness platforms, as well as personalized offerings and recommendations, makes precision biotics more readily available, while competitive prices, broad product availability, and delivery at home keep boosting sales online.
“North America is expected to hold a significant share in the global precision biotics market owing to its advanced microbiome research ecosystem & strong industry presence”
North America holds the major share in the precision biotics market owing to the well-developed research ecosystem for microbiome, the presence of prominent precision biotics firms, and the use of personalized nutrition and preventive healthcare. Some other factors that contribute to the success of North America include the established healthcare infrastructure, rising awareness among consumers about gut health, innovations in microbiome, and access to clinically tested precision biotics.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Precision Biotics market.
Research Coverage
This research report categorizes the precision biotics market by type (precision probiotics, next generation probiotics (NGPs), synbiotics, postbiotics), end-use industry (dietary supplements, functional food & beverages, pet supplements, pharmaceutical (OTC), infant formula, cosmetics, animal feed), health/functional positioning (digestive & gastrointestinal health, women's health, pediatric & infant health, skin health, gut & brain health, metabolic health, immune health, oral & dental health), distribution channel (pharmacies, retail, specialty stores, e-commerce, DTC subscription platforms), and region (North America, Europe, Asia Pacific, Rest of the World).
The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the Precision Biotics industry. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the Precision Biotics market. This report provides a competitive analysis of emerging startups in the Precision Biotics market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.
Reasons to Buy This Report
The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall precision biotics and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
“Gut & brain segment is driving market growth due to the rising focus on the gut-brain axis and personalized mental wellness solutions”
The gut & brain sub-segment under health/functional positioning is expected to witness the fastest growth in the precision biotics market owing to the growing awareness about the gut-brain axis and rising cases of stress, anxiety, depression, and other mental conditions. The ongoing developments in microbiome science, growing scientific evidence of the impact of gut microbiota on brain function, and the need for tailored solutions for improving mental wellness are leading to the rising use of precision biotics for gut and brain health.
“E-commerce is driving market growth through expanding online retail and digital health platforms”
E-commerce is expected to become the fastest-growing route for distribution within the precision biotics market owing to the rising online purchasing trends and consumers' growing inclination toward easily available precision biotics products online. The development of online pharmacies, health and wellness platforms, as well as personalized offerings and recommendations, makes precision biotics more readily available, while competitive prices, broad product availability, and delivery at home keep boosting sales online.
“North America is expected to hold a significant share in the global precision biotics market owing to its advanced microbiome research ecosystem & strong industry presence”
North America holds the major share in the precision biotics market owing to the well-developed research ecosystem for microbiome, the presence of prominent precision biotics firms, and the use of personalized nutrition and preventive healthcare. Some other factors that contribute to the success of North America include the established healthcare infrastructure, rising awareness among consumers about gut health, innovations in microbiome, and access to clinically tested precision biotics.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Precision Biotics market.
- By Company Type: Tier 1 – 30%, Tier 2 – 25%, and Tier 3 – 45%
- By Designation: CXOs – 25%, Managers – 35%, Others – 40%
- By Region: North America – 20%, Europe – 30%, Asia Pacific – 35%, and Rest of the World – 5%
Research Coverage
This research report categorizes the precision biotics market by type (precision probiotics, next generation probiotics (NGPs), synbiotics, postbiotics), end-use industry (dietary supplements, functional food & beverages, pet supplements, pharmaceutical (OTC), infant formula, cosmetics, animal feed), health/functional positioning (digestive & gastrointestinal health, women's health, pediatric & infant health, skin health, gut & brain health, metabolic health, immune health, oral & dental health), distribution channel (pharmacies, retail, specialty stores, e-commerce, DTC subscription platforms), and region (North America, Europe, Asia Pacific, Rest of the World).
The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the Precision Biotics industry. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the Precision Biotics market. This report provides a competitive analysis of emerging startups in the Precision Biotics market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.
Reasons to Buy This Report
The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall precision biotics and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
- Analysis of key drivers (Growing Adoption of Personalized & Targeted Nutrition and Microbiome-based Healthcare, Growing Incidence of Gastrointestinal Disorders), restraints (High Development Costs of Strain-Specific Precision Biotics, Complex Regulatory Pathways for Personalized Microbiome Products), opportunities (Increasing Partnerships Between Biotech Firms and Healthcare Providers, Rising Demand for Precision Nutrition in Chronic Disease Management), and challenges (Ensuring Strain Stability and Product Quality Across Supply Chains, Need for Robust Clinical Evidence to Support Health Claims)
- Product Development/Innovation: Detailed insights into research & development activities and product launches in the precision biotics market
- Market Development: Comprehensive information about lucrative markets—analysis of precision biotics across varied regions
- Market Diversification: Exhaustive information about product sources, untapped geographies, recent developments, and investments in the precision biotics market
- Competitive Assessment: In depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Darling Ingredients (US), Tessenderlo Group (Belgium) - BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)-(Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), Infinant Health Inc (US), and other players in the precision biotics market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE AND SEGMENTATION
1.3.1 YEARS CONSIDERED
1.3.2 CURRENCY CONSIDERED
1.3.3 UNIT CONSIDERED
1.4 STAKEHOLDERS
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN PRECISION BIOTICS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PRECISION BIOTICS MARKET
3.2 PRECISION BIOTICS MARKET, BY TYPE AND REGION
3.3 PRECISION BIOTICS MARKET, BY TOP THREE TYPES
3.4 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL
3.5 PRECISION BIOTICS MARKET, BY TOP FOUR HEALTH/ FUNCTIONAL POSITIONINGS
3.6 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY
3.7 PRECISION BIOTICS MARKET, BY COUNTRY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Growing adoption of personalized & targeted nutrition and microbiome-based healthcare
4.2.1.2 Growing incidence of gastrointestinal disorders
4.2.1.3 Growing consumer focus on preventive healthcare
4.2.2 RESTRAINTS
4.2.2.1 High development costs of strain-specific precision biotics
4.2.2.2 Complex regulatory pathways for personalized microbiome products
4.2.3 OPPORTUNITIES
4.2.3.1 Increasing partnerships between biotech firms and healthcare providers
4.2.3.2 Rising demand for precision nutrition in chronic disease management
4.2.3.3 Growing integration of AI and multi-omics technologies in product development & advancement in the microbiome sequencing
4.2.4 CHALLENGES
4.2.4.1 Ensuring strain stability and product quality across supply chains
4.2.4.2 Need for robust clinical evidence to support health claims
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN PRECISION BIOTICS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
4.5.1 KEY MOVES AND STRATEGIC FOCUS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 INTENSITY OF COMPETITIVE RIVALRY
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 THREAT OF NEW ENTRANTS
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 MACROECONOMIC INDICATORS
5.2.2.1 Aging demographics fuel growth of north american probiotics market
5.2.2.2 Increasing national healthcare expenditure
5.2.2.3 Increasing prevalence of lifestyle-related chronic disorders
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & CONSUMER PRODUCT DEVELOPMENT
5.3.2 INGREDIENT SOURCING & STRAIN DEVELOPMENT
5.3.3 MANUFACTURING & PRODUCT FORMULATION
5.3.4 DISTRIBUTION, RETAIL & SUPPLY CHAIN MANAGEMENT
5.3.5 CONSUMER APPLICATIONS & COMMERCIALIZATION
5.4 ECOSYSTEM/MARKET MAP ANALYSES
5.4.1 DEMAND SIDE
5.4.2 SUPPLY SIDE
5.5 PRICING ANALYSIS
5.5.1 INTRODUCTION
5.5.2 INDICATIVE PRICE TREND AMONG MARKET PLAYERS
5.5.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION
5.5.4 AVERAGE SELLING PRICE (ASP) TREND BY TYPE, 2022–2025 (USD/TONS)
5.6 TRADE ANALYSIS
5.6.1 IMPORT ANALYSIS: PRECISION BIOTICS
5.6.2 EXPORT ANALYSIS: PRECISION BIOTICS
5.7 KEY CONFERENCES AND EVENTS, 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 PENDULUM – LAUNCH OF PENDULUM GLUCOSE CONTROL FOR PRECISION BLOOD SUGAR MANAGEMENT
5.10.2 BIOGAIA – LAUNCH OF BIOGAIA PROTECTIS PLUS NEXT-GENERATION PATENTED PROBIOTIC DROPS
5.10.3 FLOR? (SUN GENOMICS) – DEVELOPMENT OF PRECISION SYNBIOTICS FOR AUTISM SPECTRUM DISORDER SUPPORT
5.10.4 VIOME – LAUNCH OF VRX MY·BIOTICS TOOTHPASTE & GEL FOR PERSONALIZED ORAL MICROBIOME HEALTH
5.11 IMPACT OF 2025 US TARIFF –PRECISION BIOTICS MARKET
5.11.1 INTRODUCTION
5.11.2 PRICE IMPACT ANALYSIS
5.11.3 IMPACT ON COUNTRIES/REGIONS
5.11.3.1 US
5.11.3.2 Europe
5.11.3.3 Asia Pacific
5.11.4 IMPACT ON END USE INDUSTRIES
6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY TECHNOLOGIES
6.1.1.1 Next-generation sequencing (NGS)
6.1.1.2 Precision fermentation & strain engineering
6.1.2 COMPLEMENTARY ANALYSIS
6.1.2.1 Microencapsulation & controlled release delivery systems
6.1.2.2 Synbiotic formulation technologies
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 Bioprocess automation & smart manufacturing
6.1.3.2 Metabolomics platforms
6.2 PATENT ANALYSIS
6.3 FUTURE APPLICATIONS
6.3.1 SMART (DISEASE-SENSING) PROBIOTICS: ENABLING THE NEXT GENERATION OF PRECISION BIOTICS
6.3.2 ENGINEERED LIVE BIOTHERAPEUTICS: SHAPING THE FUTURE OF PRECISION BIOTICS
6.3.3 ENGINEERED PRECISION PROBIOTICS FOR INFLAMMATORY BOWEL DISEASE (IBD): ADVANCING TARGETED MICROBIOME THERAPEUTICS
6.3.4 POSTBIOTICS FOR NEXT-GENERATION FUNCTIONAL FOODS AND BIOPRESERVATION
6.4 IMPACT OF GENERATIVE AI ON PRECISION BIOTICS MARKET
6.4.1 INTRODUCTION
6.4.2 TOP USE CASES AND MARKET POTENTIAL
6.4.3 BEST PRACTICES IN PRECISION BIOTICS INDUSTRY
6.4.4 CASE STUDIES OF AI IMPLEMENTATION IN THE PRECISION BIOTICS MARKET
6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.4.6 CLIENTS’ READINESS TO ADOPT GENERATIVE AI FOR PRECISION BIOTICS
6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7 SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.1.3 LABELING REQUIREMENTS AND CLAIMS
7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
7.1.4.1 Enhanced strain traceability and clinical evidence requirements
7.1.4.2 Global harmonization of precision biotics regulations
7.1.4.3 Stricter clinical validation and health claim compliance
7.1.4.4 Digital traceability, AI-enabled quality monitoring, and compliance automation
7.1.4.5 Higher quality standards for live biotherapeutic and next-generation biotics
7.2 SUSTAINABILITY INITIATIVES
7.2.1 SUSTAINABLE SOURCING
7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES
7.2.3 CIRCULAR ECONOMY APPROACHES
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS AND BUYING CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
8.5 MARKET PROFITABILITY
8.6 REVENUE POTENTIAL
8.6.1 COST DYNAMICS
8.6.2 MARGIN OPPORTUNITIES, BY TYPE
9 PRECISION BIOTICS MARKET, BY TYPE
9.1 INTRODUCTION
9.2 PRECISION PROBIOTICS
9.2.1 PRECISION PROBIOTICS TO FUEL EXPANSION OF PRECISION BIOTICS MARKET
9.3 NEXT-GENERATION PROBIOTICS
9.3.1 NEXT-GENERATION PROBIOTICS DRIVING INNOVATION IN PRECISION BIOTICS MARKET
9.4 SYNBIOTICS
9.4.1 PERSONALIZED SYNBIOTICS DRIVING INNOVATION AND GROWTH IN PRECISION BIOTICS MARKET
9.5 POSTBIOTICS
9.5.1 COMMERCIALIZATION OF POSTBIOTIC PRODUCTS STRENGTHENING PRECISION BIOTICS MARKET
10 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY
10.1 INTRODUCTION
10.2 DIETARY SUPPLEMENTS
10.2.1 GROWING DIETARY SUPPLEMENT ADOPTION DRIVING GLOBAL PRECISION BIOTICS GROWTH
10.3 FUNCTIONAL FOOD & BEVERAGES
10.3.1 GROWING DEMAND FOR FUNCTIONAL FOODS DRIVING PRECISION BIOTICS ADOPTION
10.4 PET SUPPLEMENTS
10.4.1 RISING PET HUMANIZATION DRIVING PRECISION BIOTICS ADOPTION IN COMPANION ANIMAL NUTRITION
10.5 PHARMACEUTICALS (OTC)
10.5.1 GROWING OTC SELF-CARE TRENDS ACCELERATING PRECISION BIOTICS ADOPTION
10.6 INFANT FORMULA
10.6.1 EARLY-LIFE NUTRITION INNOVATION DRIVING PRECISION BIOTICS ADOPTION IN INFANT FORMULA
10.7 COSMETICS
10.7.1 GROWING INVESTMENT IN MICROBIOME-BASED BEAUTY DRIVING PRECISION BIOTICS ADOPTION
10.8 ANIMAL FEED
10.8.1 SUSTAINABLE ANIMAL NUTRITION DRIVING PRECISION BIOTICS ADOPTION
11 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL
11.1 INTRODUCTION
11.2 PHARMACIES
11.2.1 PHARMACIES ACCELERATING ADOPTION OF PRECISION BIOTICS ACROSS GLOBE
11.3 RETAIL
11.3.1 EXPANDING ORGANIZED RETAIL NETWORKS STRENGTHEN CONSUMER ACCESS TO PRECISION BIOTICS
11.4 SPECIALTY STORES
11.4.1 SPECIALTY HEALTH STORES ENHANCE CONSUMER ACCESS TO PRECISION BIOTICS GLOBALLY
11.5 E-COMMERCE
11.5.1 EXPANDING E-COMMERCE PLATFORMS ACCELERATE PRECISION BIOTICS ADOPTION GLOBALLY
11.6 DTC SUBSCRIPTION PLATFORMS
11.6.1 DIRECT-TO-CONSUMER (DTC) SUBSCRIPTION PLATFORMS EXPAND GLOBAL PRECISION BIOTICS ACCESSIBILITY
12 PRECISION BIOTICS MARKET, BY HEALTH/ FUNCTIONAL POSITIONING
12.1 INTRODUCTION
12.2 DIGESTIVE & GASTROINTESTINAL HEALTH
12.2.1 MICROBIOME-BASED DIGESTIVE & GASTROINTESTINAL HEALTH SOLUTIONS ACCELERATING MARKET GROWTH
12.3 WOMEN’S HEALTH
12.3.1 ADVANCING WOMEN'S HEALTH THROUGH PRECISION MICROBIOME INNOVATION
12.4 PEDIATRIC & INFANT HEALTH
12.4.1 PEDIATRIC & INFANT HEALTH DRIVING GROWTH OF PRECISION BIOTICS MARKET
12.5 SKIN HEALTH
12.5.1 GROWING BURDEN OF SKIN DISORDERS DRIVING GLOBAL PRECISION BIOTICS ADOPTION
12.6 GUT & BRAIN HEALTH
12.6.1 GROWING MENTAL HEALTH BURDEN ACCELERATING PRECISION BIOTICS ADOPTION THROUGH GUT–BRAIN AXIS
12.7 METABOLIC HEALTH
12.7.1 GROWING BURDEN OF DIABETES AND PREDIABETES ACCELERATING PRECISION BIOTICS ADOPTION
12.8 IMMUNE HEALTH
12.8.1 GROWING FOCUS ON PREVENTIVE IMMUNITY DRIVING GLOBAL PRECISION BIOTICS ADOPTION
12.9 ORAL & DENTAL HEALTH
12.9.1 GROWING FOCUS ON PREVENTIVE IMMUNITY DRIVING GLOBAL PRECISION BIOTICS ADOPTION
13 PRECISION BIOTICS MARKET, BY REGION
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.2.1 US
13.2.1.1 Growing government investments, precision nutrition initiatives, and strategic collaborations driving US precision biotics market
13.2.2 CANADA
13.2.2.1 Government investments, expanding genomics ecosystem and commercialization programs accelerating Canadian precision biotics market
13.3 EUROPE
13.3.1 GERMANY
13.3.1.1 Precision Biotics Market Driven by Clinical Research and Personalized Nutrition
13.3.2 UK
13.3.2.1 Increasing Burden of Gastrointestinal Disorders Fueling Precision Biotics Demand
13.3.3 FRANCE
13.3.3.1 Growing Consumer Awareness and Personalized Nutrition Supporting Precision Biotics
13.3.4 ITALY
13.3.4.1 Strong Dietary Supplement Adoption Accelerates Precision Biotics Market Growth in Italy
13.3.5 SPAIN
13.3.5.1 Growing precision medicine and microbiome research drive Spain's precision biotics market
13.3.6 REST OF EUROPE
13.4 ASIA PACIFIC
13.4.1 CHINA
13.4.1.1 Expanding nutritional supplements industry accelerating precision biotics adoption in China
13.4.2 INDIA
13.4.2.1 Rising consumer awareness of gut health and preventive healthcare drives precision biotics market growth
13.4.3 JAPAN
13.4.3.1 Growing pharmaceutical investments support Japan's precision biotics market
13.4.4 AUSTRALIA & NEW ZEALAND
13.4.4.1 Advanced life sciences research and preventive healthcare drive the Australia & New Zealand precision biotics market
13.4.5 REST OF ASIA PACIFIC
13.5 REST OF THE WORLD (ROW)
13.5.1 LATIN AMERICA
13.5.1.1 Rising obesity and metabolic disorders drive precision biotics market growth
13.5.2 MIDDLE EAST
13.5.2.1 Expanding pharmaceutical manufacturing and precision medicine drive precision biotics market growth
13.5.3 AFRICA
13.5.3.1 Rising awareness of gut health and personalized nutrition supports market growth
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
14.3 REVENUE ANALYSIS, 2023–2025
14.4 MARKET SHARE ANALYSIS, 2025
14.5 COMPANY VALUATION AND FINANCIAL METRICS
14.5.1 COMPANY VALUATION
14.5.2 EV/EBITDA
14.6 BRAND COMPARISON ANALYSIS, BY TYPE
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
14.7.1 STARS
14.7.2 EMERGING LEADERS
14.7.3 PERVASIVE PLAYERS
14.7.4 PARTICIPANTS
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS
14.7.5.1 Regional footprint
14.7.5.2 Type footprint
14.7.5.3 Function footprint
14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
14.8.1 PROGRESSIVE COMPANIES
14.8.2 RESPONSIVE COMPANIES
14.8.3 DYNAMIC COMPANIES
14.8.4 STARTING BLOCKS
14.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025
14.8.5.1 Detailed list of key startups/SMEs
14.8.5.2 Competitive benchmarking of key startups/SMEs
14.9 COMPETITIVE SCENARIO AND TRENDS
14.9.1 PRODUCT LAUNCHES
14.9.2 DEALS
15 COMPANY PROFILES
15.1 KEY PLAYERS
15.1.1 BIOGAIA
15.1.1.1 Business overview
15.1.1.2 Products/Solutions/Services offered
15.1.1.3 Recent developments
15.1.1.3.1 Product launches
15.1.1.3.2 Deals
15.1.1.4 MnM view
15.1.1.4.1 Key strengths
15.1.1.4.2 Strategic choices
15.1.1.4.3 Weaknesses & competitive threats
15.1.2 NOVONESIS GROUP
15.1.2.1 Business overview
15.1.2.2 Products/Solutions/Services offered
15.1.2.3 Recent developments
15.1.2.3.1 Deals
15.1.2.4 MnM view
15.1.2.4.1 Key strengths
15.1.2.4.2 Strategic choices
15.1.2.4.3 Weaknesses & competitive threats
15.1.3 PROCTER & GAMBLE
15.1.3.1 Business overview
15.1.3.2 Products/Solutions/Services offered
15.1.3.3 MnM view
15.1.3.3.1 Key strengths
15.1.3.3.2 Strategic choices
15.1.3.3.3 Weaknesses & competitive threats
15.1.4 UNILEVER
15.1.4.1 Business overview
15.1.4.2 Products/Solutions/Services offered
15.1.4.3 Recent developments
15.1.4.3.1 Product launches
15.1.4.4 MnM view
15.1.4.4.1 Key strengths
15.1.4.4.2 Strategic choices
15.1.4.4.3 Weaknesses & competitive threats
15.1.5 DSM-FIRMENICH GROUP (CULTURELLE)
15.1.5.1 Business overview
15.1.5.2 Products/Solutions/Services offered
15.1.5.2.1 Deals
15.1.5.3 MnM view
15.1.5.3.1 Key strengths
15.1.5.3.2 Strategic choices
15.1.5.3.3 Weaknesses & competitive threats
15.1.6 NESTL? (NESTL? HEALTH SCIENCE)
15.1.6.1 Business overview
15.1.6.2 Products/Solutions/Services offered
15.1.6.3 MnM view
15.1.7 METAGENICS, LLC
15.1.7.1 Business overview
15.1.7.2 Products/Solutions/Services offered
15.1.7.3 Recent developments
15.1.7.3.1 Deals
15.1.7.4 MnM view
15.1.8 YAKULT HONSHA CO., LTD.
15.1.8.1 Business overview
15.1.8.2 Products/Solutions/Services offered
15.1.8.3 Recent developments
15.1.8.3.1 Product launches
15.1.8.4 MnM view
15.1.9 DANONE
15.1.9.1 Business overview
15.1.9.2 Products/Solutions/Services offered
15.1.9.3 Recent developments
15.1.9.3.1 Deals
15.1.9.4 MnM view
15.1.10 KANEKA CORPORATION (AB-BIOTICS)
15.1.10.1 Business overview
15.1.10.2 Products/Solutions/Services offered
15.1.10.3 Recent developments
15.1.10.3.1 Product launches
15.1.10.4 MnM view
15.1.11 SYMRISE GROUP (PROBI): BUSINESS OVERVIEW
15.1.11.1 Products/Solutions/Services offered
15.1.11.2 MnM view
15.1.12 JARROW FORMULAS, INC
15.1.12.1 Business overview
15.1.12.2 Products/Solutions/Services offered
15.1.12.3 MnM view
15.1.13 PENDULUM
15.1.13.1 Business overview
15.1.13.2 Products/Solutions/Services offered
15.1.13.3 Recent developments
15.1.13.3.1 Product launches
15.1.13.4 MnM view
15.1.14 THE GOOD BUG
15.1.14.1 Business overview
15.1.14.2 Products/Solutions/Services offered
15.1.14.3 MnM view
15.1.15 SEED HEALTH INC
15.1.15.1 Business overview
15.1.15.2 Products/Solutions/Services offered
15.1.15.3 MnM view
15.2 OTHER PLAYERS
15.2.1 INFINANT HEALTH INC.
15.2.1.1 Business overview
15.2.1.2 Products/Solutions/Services offered
15.2.1.3 MnM view
15.2.2 VIOME LIFE SCIENCES, INC.
15.2.2.1 Business overview
15.2.2.2 Products/Solutions/Services offered
15.2.2.2.1 Product launches
15.2.2.3 MnM view
15.2.3 BLACKMORES
15.2.3.1 Business overview
15.2.3.2 Products/Solutions/Services offered
15.2.3.3 MnM view
15.2.4 LAYER ORIGIN NUTRITION
15.2.4.1 Business overview
15.2.4.2 Products/Solutions/Services offered
15.2.4.3 Recent developments
15.2.4.4 MnM view
15.2.5 RESBIOTIC
15.2.5.1 Business overview
15.2.5.2 Products/Solutions/Services offered
15.2.5.3 Recent developments
15.2.5.3.1 Product launches
15.2.5.4 MnM view
15.2.6 FITBIOMICS
15.2.7 FLORE INC
15.2.8 ZBIOTICS
15.2.9 BIOHM TECHNOLOGIES
15.2.10 MRO MARYRUTH, LLC.
16 RESEARCH METHODOLOGY
16.1 RESEARCH DATA
16.1.1 SECONDARY DATA
16.1.1.1 Key data from secondary sources
16.1.2 PRIMARY DATA
16.1.2.1 Key data from primary sources
16.1.2.2 Breakdown of primary profiles
16.1.2.3 Key insights from industry experts
16.2 MARKET SIZE ESTIMATION
16.2.1 TOP-DOWN APPROACH
16.2.2 SUPPLY-SIDE ANALYSIS
16.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
16.3 DATA TRIANGULATION AND MARKET BREAKUP
16.4 RESEARCH ASSUMPTIONS
16.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT
17 ADJACENT AND RELATED MARKETS
17.1 INTRODUCTION
17.2 RESEARCH LIMITATIONS
17.3 PROBIOTIC SUPPLEMENTS MARKET
17.3.1 MARKET DEFINITION
17.3.2 MARKET OVERVIEW
17.4 PROBIOTICS MARKET
17.4.1 MARKET DEFINITION
17.4.2 MARKET OVERVIEW
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE AND SEGMENTATION
1.3.1 YEARS CONSIDERED
1.3.2 CURRENCY CONSIDERED
1.3.3 UNIT CONSIDERED
1.4 STAKEHOLDERS
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN PRECISION BIOTICS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PRECISION BIOTICS MARKET
3.2 PRECISION BIOTICS MARKET, BY TYPE AND REGION
3.3 PRECISION BIOTICS MARKET, BY TOP THREE TYPES
3.4 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL
3.5 PRECISION BIOTICS MARKET, BY TOP FOUR HEALTH/ FUNCTIONAL POSITIONINGS
3.6 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY
3.7 PRECISION BIOTICS MARKET, BY COUNTRY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Growing adoption of personalized & targeted nutrition and microbiome-based healthcare
4.2.1.2 Growing incidence of gastrointestinal disorders
4.2.1.3 Growing consumer focus on preventive healthcare
4.2.2 RESTRAINTS
4.2.2.1 High development costs of strain-specific precision biotics
4.2.2.2 Complex regulatory pathways for personalized microbiome products
4.2.3 OPPORTUNITIES
4.2.3.1 Increasing partnerships between biotech firms and healthcare providers
4.2.3.2 Rising demand for precision nutrition in chronic disease management
4.2.3.3 Growing integration of AI and multi-omics technologies in product development & advancement in the microbiome sequencing
4.2.4 CHALLENGES
4.2.4.1 Ensuring strain stability and product quality across supply chains
4.2.4.2 Need for robust clinical evidence to support health claims
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN PRECISION BIOTICS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
4.5.1 KEY MOVES AND STRATEGIC FOCUS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 INTENSITY OF COMPETITIVE RIVALRY
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 THREAT OF NEW ENTRANTS
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 MACROECONOMIC INDICATORS
5.2.2.1 Aging demographics fuel growth of north american probiotics market
5.2.2.2 Increasing national healthcare expenditure
5.2.2.3 Increasing prevalence of lifestyle-related chronic disorders
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & CONSUMER PRODUCT DEVELOPMENT
5.3.2 INGREDIENT SOURCING & STRAIN DEVELOPMENT
5.3.3 MANUFACTURING & PRODUCT FORMULATION
5.3.4 DISTRIBUTION, RETAIL & SUPPLY CHAIN MANAGEMENT
5.3.5 CONSUMER APPLICATIONS & COMMERCIALIZATION
5.4 ECOSYSTEM/MARKET MAP ANALYSES
5.4.1 DEMAND SIDE
5.4.2 SUPPLY SIDE
5.5 PRICING ANALYSIS
5.5.1 INTRODUCTION
5.5.2 INDICATIVE PRICE TREND AMONG MARKET PLAYERS
5.5.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION
5.5.4 AVERAGE SELLING PRICE (ASP) TREND BY TYPE, 2022–2025 (USD/TONS)
5.6 TRADE ANALYSIS
5.6.1 IMPORT ANALYSIS: PRECISION BIOTICS
5.6.2 EXPORT ANALYSIS: PRECISION BIOTICS
5.7 KEY CONFERENCES AND EVENTS, 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 PENDULUM – LAUNCH OF PENDULUM GLUCOSE CONTROL FOR PRECISION BLOOD SUGAR MANAGEMENT
5.10.2 BIOGAIA – LAUNCH OF BIOGAIA PROTECTIS PLUS NEXT-GENERATION PATENTED PROBIOTIC DROPS
5.10.3 FLOR? (SUN GENOMICS) – DEVELOPMENT OF PRECISION SYNBIOTICS FOR AUTISM SPECTRUM DISORDER SUPPORT
5.10.4 VIOME – LAUNCH OF VRX MY·BIOTICS TOOTHPASTE & GEL FOR PERSONALIZED ORAL MICROBIOME HEALTH
5.11 IMPACT OF 2025 US TARIFF –PRECISION BIOTICS MARKET
5.11.1 INTRODUCTION
5.11.2 PRICE IMPACT ANALYSIS
5.11.3 IMPACT ON COUNTRIES/REGIONS
5.11.3.1 US
5.11.3.2 Europe
5.11.3.3 Asia Pacific
5.11.4 IMPACT ON END USE INDUSTRIES
6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY TECHNOLOGIES
6.1.1.1 Next-generation sequencing (NGS)
6.1.1.2 Precision fermentation & strain engineering
6.1.2 COMPLEMENTARY ANALYSIS
6.1.2.1 Microencapsulation & controlled release delivery systems
6.1.2.2 Synbiotic formulation technologies
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 Bioprocess automation & smart manufacturing
6.1.3.2 Metabolomics platforms
6.2 PATENT ANALYSIS
6.3 FUTURE APPLICATIONS
6.3.1 SMART (DISEASE-SENSING) PROBIOTICS: ENABLING THE NEXT GENERATION OF PRECISION BIOTICS
6.3.2 ENGINEERED LIVE BIOTHERAPEUTICS: SHAPING THE FUTURE OF PRECISION BIOTICS
6.3.3 ENGINEERED PRECISION PROBIOTICS FOR INFLAMMATORY BOWEL DISEASE (IBD): ADVANCING TARGETED MICROBIOME THERAPEUTICS
6.3.4 POSTBIOTICS FOR NEXT-GENERATION FUNCTIONAL FOODS AND BIOPRESERVATION
6.4 IMPACT OF GENERATIVE AI ON PRECISION BIOTICS MARKET
6.4.1 INTRODUCTION
6.4.2 TOP USE CASES AND MARKET POTENTIAL
6.4.3 BEST PRACTICES IN PRECISION BIOTICS INDUSTRY
6.4.4 CASE STUDIES OF AI IMPLEMENTATION IN THE PRECISION BIOTICS MARKET
6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.4.6 CLIENTS’ READINESS TO ADOPT GENERATIVE AI FOR PRECISION BIOTICS
6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7 SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.1.3 LABELING REQUIREMENTS AND CLAIMS
7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
7.1.4.1 Enhanced strain traceability and clinical evidence requirements
7.1.4.2 Global harmonization of precision biotics regulations
7.1.4.3 Stricter clinical validation and health claim compliance
7.1.4.4 Digital traceability, AI-enabled quality monitoring, and compliance automation
7.1.4.5 Higher quality standards for live biotherapeutic and next-generation biotics
7.2 SUSTAINABILITY INITIATIVES
7.2.1 SUSTAINABLE SOURCING
7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES
7.2.3 CIRCULAR ECONOMY APPROACHES
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS AND BUYING CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
8.5 MARKET PROFITABILITY
8.6 REVENUE POTENTIAL
8.6.1 COST DYNAMICS
8.6.2 MARGIN OPPORTUNITIES, BY TYPE
9 PRECISION BIOTICS MARKET, BY TYPE
9.1 INTRODUCTION
9.2 PRECISION PROBIOTICS
9.2.1 PRECISION PROBIOTICS TO FUEL EXPANSION OF PRECISION BIOTICS MARKET
9.3 NEXT-GENERATION PROBIOTICS
9.3.1 NEXT-GENERATION PROBIOTICS DRIVING INNOVATION IN PRECISION BIOTICS MARKET
9.4 SYNBIOTICS
9.4.1 PERSONALIZED SYNBIOTICS DRIVING INNOVATION AND GROWTH IN PRECISION BIOTICS MARKET
9.5 POSTBIOTICS
9.5.1 COMMERCIALIZATION OF POSTBIOTIC PRODUCTS STRENGTHENING PRECISION BIOTICS MARKET
10 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY
10.1 INTRODUCTION
10.2 DIETARY SUPPLEMENTS
10.2.1 GROWING DIETARY SUPPLEMENT ADOPTION DRIVING GLOBAL PRECISION BIOTICS GROWTH
10.3 FUNCTIONAL FOOD & BEVERAGES
10.3.1 GROWING DEMAND FOR FUNCTIONAL FOODS DRIVING PRECISION BIOTICS ADOPTION
10.4 PET SUPPLEMENTS
10.4.1 RISING PET HUMANIZATION DRIVING PRECISION BIOTICS ADOPTION IN COMPANION ANIMAL NUTRITION
10.5 PHARMACEUTICALS (OTC)
10.5.1 GROWING OTC SELF-CARE TRENDS ACCELERATING PRECISION BIOTICS ADOPTION
10.6 INFANT FORMULA
10.6.1 EARLY-LIFE NUTRITION INNOVATION DRIVING PRECISION BIOTICS ADOPTION IN INFANT FORMULA
10.7 COSMETICS
10.7.1 GROWING INVESTMENT IN MICROBIOME-BASED BEAUTY DRIVING PRECISION BIOTICS ADOPTION
10.8 ANIMAL FEED
10.8.1 SUSTAINABLE ANIMAL NUTRITION DRIVING PRECISION BIOTICS ADOPTION
11 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL
11.1 INTRODUCTION
11.2 PHARMACIES
11.2.1 PHARMACIES ACCELERATING ADOPTION OF PRECISION BIOTICS ACROSS GLOBE
11.3 RETAIL
11.3.1 EXPANDING ORGANIZED RETAIL NETWORKS STRENGTHEN CONSUMER ACCESS TO PRECISION BIOTICS
11.4 SPECIALTY STORES
11.4.1 SPECIALTY HEALTH STORES ENHANCE CONSUMER ACCESS TO PRECISION BIOTICS GLOBALLY
11.5 E-COMMERCE
11.5.1 EXPANDING E-COMMERCE PLATFORMS ACCELERATE PRECISION BIOTICS ADOPTION GLOBALLY
11.6 DTC SUBSCRIPTION PLATFORMS
11.6.1 DIRECT-TO-CONSUMER (DTC) SUBSCRIPTION PLATFORMS EXPAND GLOBAL PRECISION BIOTICS ACCESSIBILITY
12 PRECISION BIOTICS MARKET, BY HEALTH/ FUNCTIONAL POSITIONING
12.1 INTRODUCTION
12.2 DIGESTIVE & GASTROINTESTINAL HEALTH
12.2.1 MICROBIOME-BASED DIGESTIVE & GASTROINTESTINAL HEALTH SOLUTIONS ACCELERATING MARKET GROWTH
12.3 WOMEN’S HEALTH
12.3.1 ADVANCING WOMEN'S HEALTH THROUGH PRECISION MICROBIOME INNOVATION
12.4 PEDIATRIC & INFANT HEALTH
12.4.1 PEDIATRIC & INFANT HEALTH DRIVING GROWTH OF PRECISION BIOTICS MARKET
12.5 SKIN HEALTH
12.5.1 GROWING BURDEN OF SKIN DISORDERS DRIVING GLOBAL PRECISION BIOTICS ADOPTION
12.6 GUT & BRAIN HEALTH
12.6.1 GROWING MENTAL HEALTH BURDEN ACCELERATING PRECISION BIOTICS ADOPTION THROUGH GUT–BRAIN AXIS
12.7 METABOLIC HEALTH
12.7.1 GROWING BURDEN OF DIABETES AND PREDIABETES ACCELERATING PRECISION BIOTICS ADOPTION
12.8 IMMUNE HEALTH
12.8.1 GROWING FOCUS ON PREVENTIVE IMMUNITY DRIVING GLOBAL PRECISION BIOTICS ADOPTION
12.9 ORAL & DENTAL HEALTH
12.9.1 GROWING FOCUS ON PREVENTIVE IMMUNITY DRIVING GLOBAL PRECISION BIOTICS ADOPTION
13 PRECISION BIOTICS MARKET, BY REGION
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.2.1 US
13.2.1.1 Growing government investments, precision nutrition initiatives, and strategic collaborations driving US precision biotics market
13.2.2 CANADA
13.2.2.1 Government investments, expanding genomics ecosystem and commercialization programs accelerating Canadian precision biotics market
13.3 EUROPE
13.3.1 GERMANY
13.3.1.1 Precision Biotics Market Driven by Clinical Research and Personalized Nutrition
13.3.2 UK
13.3.2.1 Increasing Burden of Gastrointestinal Disorders Fueling Precision Biotics Demand
13.3.3 FRANCE
13.3.3.1 Growing Consumer Awareness and Personalized Nutrition Supporting Precision Biotics
13.3.4 ITALY
13.3.4.1 Strong Dietary Supplement Adoption Accelerates Precision Biotics Market Growth in Italy
13.3.5 SPAIN
13.3.5.1 Growing precision medicine and microbiome research drive Spain's precision biotics market
13.3.6 REST OF EUROPE
13.4 ASIA PACIFIC
13.4.1 CHINA
13.4.1.1 Expanding nutritional supplements industry accelerating precision biotics adoption in China
13.4.2 INDIA
13.4.2.1 Rising consumer awareness of gut health and preventive healthcare drives precision biotics market growth
13.4.3 JAPAN
13.4.3.1 Growing pharmaceutical investments support Japan's precision biotics market
13.4.4 AUSTRALIA & NEW ZEALAND
13.4.4.1 Advanced life sciences research and preventive healthcare drive the Australia & New Zealand precision biotics market
13.4.5 REST OF ASIA PACIFIC
13.5 REST OF THE WORLD (ROW)
13.5.1 LATIN AMERICA
13.5.1.1 Rising obesity and metabolic disorders drive precision biotics market growth
13.5.2 MIDDLE EAST
13.5.2.1 Expanding pharmaceutical manufacturing and precision medicine drive precision biotics market growth
13.5.3 AFRICA
13.5.3.1 Rising awareness of gut health and personalized nutrition supports market growth
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
14.3 REVENUE ANALYSIS, 2023–2025
14.4 MARKET SHARE ANALYSIS, 2025
14.5 COMPANY VALUATION AND FINANCIAL METRICS
14.5.1 COMPANY VALUATION
14.5.2 EV/EBITDA
14.6 BRAND COMPARISON ANALYSIS, BY TYPE
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
14.7.1 STARS
14.7.2 EMERGING LEADERS
14.7.3 PERVASIVE PLAYERS
14.7.4 PARTICIPANTS
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS
14.7.5.1 Regional footprint
14.7.5.2 Type footprint
14.7.5.3 Function footprint
14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
14.8.1 PROGRESSIVE COMPANIES
14.8.2 RESPONSIVE COMPANIES
14.8.3 DYNAMIC COMPANIES
14.8.4 STARTING BLOCKS
14.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025
14.8.5.1 Detailed list of key startups/SMEs
14.8.5.2 Competitive benchmarking of key startups/SMEs
14.9 COMPETITIVE SCENARIO AND TRENDS
14.9.1 PRODUCT LAUNCHES
14.9.2 DEALS
15 COMPANY PROFILES
15.1 KEY PLAYERS
15.1.1 BIOGAIA
15.1.1.1 Business overview
15.1.1.2 Products/Solutions/Services offered
15.1.1.3 Recent developments
15.1.1.3.1 Product launches
15.1.1.3.2 Deals
15.1.1.4 MnM view
15.1.1.4.1 Key strengths
15.1.1.4.2 Strategic choices
15.1.1.4.3 Weaknesses & competitive threats
15.1.2 NOVONESIS GROUP
15.1.2.1 Business overview
15.1.2.2 Products/Solutions/Services offered
15.1.2.3 Recent developments
15.1.2.3.1 Deals
15.1.2.4 MnM view
15.1.2.4.1 Key strengths
15.1.2.4.2 Strategic choices
15.1.2.4.3 Weaknesses & competitive threats
15.1.3 PROCTER & GAMBLE
15.1.3.1 Business overview
15.1.3.2 Products/Solutions/Services offered
15.1.3.3 MnM view
15.1.3.3.1 Key strengths
15.1.3.3.2 Strategic choices
15.1.3.3.3 Weaknesses & competitive threats
15.1.4 UNILEVER
15.1.4.1 Business overview
15.1.4.2 Products/Solutions/Services offered
15.1.4.3 Recent developments
15.1.4.3.1 Product launches
15.1.4.4 MnM view
15.1.4.4.1 Key strengths
15.1.4.4.2 Strategic choices
15.1.4.4.3 Weaknesses & competitive threats
15.1.5 DSM-FIRMENICH GROUP (CULTURELLE)
15.1.5.1 Business overview
15.1.5.2 Products/Solutions/Services offered
15.1.5.2.1 Deals
15.1.5.3 MnM view
15.1.5.3.1 Key strengths
15.1.5.3.2 Strategic choices
15.1.5.3.3 Weaknesses & competitive threats
15.1.6 NESTL? (NESTL? HEALTH SCIENCE)
15.1.6.1 Business overview
15.1.6.2 Products/Solutions/Services offered
15.1.6.3 MnM view
15.1.7 METAGENICS, LLC
15.1.7.1 Business overview
15.1.7.2 Products/Solutions/Services offered
15.1.7.3 Recent developments
15.1.7.3.1 Deals
15.1.7.4 MnM view
15.1.8 YAKULT HONSHA CO., LTD.
15.1.8.1 Business overview
15.1.8.2 Products/Solutions/Services offered
15.1.8.3 Recent developments
15.1.8.3.1 Product launches
15.1.8.4 MnM view
15.1.9 DANONE
15.1.9.1 Business overview
15.1.9.2 Products/Solutions/Services offered
15.1.9.3 Recent developments
15.1.9.3.1 Deals
15.1.9.4 MnM view
15.1.10 KANEKA CORPORATION (AB-BIOTICS)
15.1.10.1 Business overview
15.1.10.2 Products/Solutions/Services offered
15.1.10.3 Recent developments
15.1.10.3.1 Product launches
15.1.10.4 MnM view
15.1.11 SYMRISE GROUP (PROBI): BUSINESS OVERVIEW
15.1.11.1 Products/Solutions/Services offered
15.1.11.2 MnM view
15.1.12 JARROW FORMULAS, INC
15.1.12.1 Business overview
15.1.12.2 Products/Solutions/Services offered
15.1.12.3 MnM view
15.1.13 PENDULUM
15.1.13.1 Business overview
15.1.13.2 Products/Solutions/Services offered
15.1.13.3 Recent developments
15.1.13.3.1 Product launches
15.1.13.4 MnM view
15.1.14 THE GOOD BUG
15.1.14.1 Business overview
15.1.14.2 Products/Solutions/Services offered
15.1.14.3 MnM view
15.1.15 SEED HEALTH INC
15.1.15.1 Business overview
15.1.15.2 Products/Solutions/Services offered
15.1.15.3 MnM view
15.2 OTHER PLAYERS
15.2.1 INFINANT HEALTH INC.
15.2.1.1 Business overview
15.2.1.2 Products/Solutions/Services offered
15.2.1.3 MnM view
15.2.2 VIOME LIFE SCIENCES, INC.
15.2.2.1 Business overview
15.2.2.2 Products/Solutions/Services offered
15.2.2.2.1 Product launches
15.2.2.3 MnM view
15.2.3 BLACKMORES
15.2.3.1 Business overview
15.2.3.2 Products/Solutions/Services offered
15.2.3.3 MnM view
15.2.4 LAYER ORIGIN NUTRITION
15.2.4.1 Business overview
15.2.4.2 Products/Solutions/Services offered
15.2.4.3 Recent developments
15.2.4.4 MnM view
15.2.5 RESBIOTIC
15.2.5.1 Business overview
15.2.5.2 Products/Solutions/Services offered
15.2.5.3 Recent developments
15.2.5.3.1 Product launches
15.2.5.4 MnM view
15.2.6 FITBIOMICS
15.2.7 FLORE INC
15.2.8 ZBIOTICS
15.2.9 BIOHM TECHNOLOGIES
15.2.10 MRO MARYRUTH, LLC.
16 RESEARCH METHODOLOGY
16.1 RESEARCH DATA
16.1.1 SECONDARY DATA
16.1.1.1 Key data from secondary sources
16.1.2 PRIMARY DATA
16.1.2.1 Key data from primary sources
16.1.2.2 Breakdown of primary profiles
16.1.2.3 Key insights from industry experts
16.2 MARKET SIZE ESTIMATION
16.2.1 TOP-DOWN APPROACH
16.2.2 SUPPLY-SIDE ANALYSIS
16.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
16.3 DATA TRIANGULATION AND MARKET BREAKUP
16.4 RESEARCH ASSUMPTIONS
16.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT
17 ADJACENT AND RELATED MARKETS
17.1 INTRODUCTION
17.2 RESEARCH LIMITATIONS
17.3 PROBIOTIC SUPPLEMENTS MARKET
17.3.1 MARKET DEFINITION
17.3.2 MARKET OVERVIEW
17.4 PROBIOTICS MARKET
17.4.1 MARKET DEFINITION
17.4.2 MARKET OVERVIEW
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 INCLUSIONS AND EXCLUSIONS
TABLE 2 USD EXCHANGE RATES, 2021–2025
TABLE 3 INTERCONNECTED MARKETS
TABLE 4 PRECISION BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5 PRECISION BIOTICS MARKET: SUPPLY CHAIN (ECOSYSTEM)
TABLE 6 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON)
TABLE 7 AVERAGE SELLING PRICE (ASP) TREND BY TYPE, 2022–2025 (USD/TONS)
TABLE 8 TOP IMPORTERS OF PRECISION BIOTICS, 2022–2025 (USD)
TABLE 9 TOP EXPORTERS OF PRECISION BIOTICS, 2022–2025 (USD)
TABLE 10 PRECISION BIOTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 11 PATENTS PERTAINING TO PRECISION BIOTICS MARKET, 2021–2026
TABLE 12 TOP USE CASES AND MARKET POTENTIAL
TABLE 13 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
TABLE 14 PRECISION BIOTICS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
TABLE 15 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 INDUSTRY STANDARDS IN PRECISION BIOTICS MARKET
TABLE 22 LABELING REQUIREMENTS AND CLAIMS IN PRECISION BIOTICS MARKET
TABLE 23 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PRECISION BIOTICS MARKET
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES
TABLE 25 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
TABLE 26 UNMET NEEDS IN PRECISION BIOTICS MARKET, BY APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
TABLE 27 COST DYNAMICS IN PRECISION MARKET
TABLE 28 MARGIN OPPORTUNITIES IN PRECISION BIOTICS MARKET, BY TYPE
TABLE 29 PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 30 PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 31 PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON)
TABLE 32 PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON)
TABLE 33 PRECISION PROBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 34 PRECISION PROBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 109 TABLE 35 PRECISION PROBIOTICS MARKET, BY REGION, 2022–2025 (TONS)
TABLE 36 PRECISION PROBIOTICS MARKET, BY REGION, 2026–2031 (TONS)
TABLE 37 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 38 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 39 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2022–2025 (TONS)
TABLE 40 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2026–2031 (TONS)
TABLE 41 SYNBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 42 SYNBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 43 SYNBIOTICS MARKET, BY REGION, 2022–2025 (TONS)
TABLE 44 SYNBIOTICS MARKET, BY REGION, 2026–2031 (TONS)
TABLE 45 POSTBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 46 POSTBOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 47 POSTBIOTICS MARKET, BY REGION, 2022–2025 (TONS)
TABLE 48 POSTBOTICS MARKET, BY REGION, 2026–2031 (TONS)
TABLE 49 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION)
TABLE 50 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION)
TABLE 51 PRECISION BIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2022–2025 (USD MILLION)
TABLE 52 PRECISION BIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2026–2031 (USD MILLION)
TABLE 53 PRECISION BIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2022–2025 (USD MILLION)
TABLE 54 PRECISION BIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2026–2031 (USD MILLION)
TABLE 55 PRECISION BIOTICS MARKET IN PET SUPPLEMENTS, BY REGION, 2022–2025 (USD MILLION)
TABLE 56 PRECISION BIOTICS MARKET IN PET SUPPLEMENTS, BY REGION, 2026–2031 (USD MILLION)
TABLE 57 PRECISION BIOTICS MARKET IN PHARMACEUTICALS (OTC), BY REGION, 2022–2025 (USD MILLION)
TABLE 58 PRECISION BIOTICS MARKET IN PHARMACEUTICALS (OTC), BY REGION, 2026–2031 (USD MILLION)
TABLE 59 PRECISION BIOTICS MARKET IN INFANT FORMULA, BY REGION, 2022–2025 (USD MILLION)
TABLE 60 PRECISION BIOTICS MARKET IN INFANT FORMULA, BY REGION, 2026–2031 (USD MILLION)
TABLE 61 PRECISION BIOTICS MARKET IN COSMETICS, BY REGION, 2022–2025 (USD MILLION)
TABLE 62 PRECISION BIOTICS MARKET IN COSMETICS, BY REGION, 2026–2031 (USD MILLION)
TABLE 63 PRECISION BIOTICS MARKET IN ANIMAL FEED, BY REGION, 2022–2025 (USD MILLION)
TABLE 64 PRECISION BIOTICS MARKET IN ANIMAL FEED, BY REGION, 2026–2031 (USD MILLION)
TABLE 65 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 128 TABLE 66 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION)
TABLE 67 PRECISION BIOTICS MARKET FROM PHARMACIES, BY REGION, 2022–2025 (USD MILLION)
TABLE 68 PRECISION BIOTICS MARKET FROM PHARMACIES, BY REGION, 2026–2031 (USD MILLION)
TABLE 69 PRECISION BIOTICS MARKET FROM RETAIL, BY REGION, 2022–2025 (USD MILLION)
TABLE 70 PRECISION BIOTICS MARKET FROM RETAIL, BY REGION, 2026–2031 (USD MILLION)
TABLE 71 PRECISION BIOTICS MARKET FROM SPECIALTY STORES, BY REGION, 2022–2025 (USD MILLION)
TABLE 72 SPECIALTY STORES: PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 73 PRECISION BIOTICS MARKET FROM E-COMMERCE, BY REGION, 2022–2025 (USD MILLION)
TABLE 74 PRECISION BIOTICS MARKET FROM E-COMMERCE, BY REGION, 2026–2031 (USD MILLION)
TABLE 75 PRECISION BIOTICS MARKET FROM DTC SUBSCRIPTION PLATFORMS, BY REGION, 2022–2025 (USD MILLION)
TABLE 76 PRECISION BIOTICS MARKET FROM DTC SUBSCRIPTION PLATFORMS, BY REGION, 2026–2031 (USD MILLION)
TABLE 77 PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION)
TABLE 78 PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION)
TABLE 79 PRECISION BIOTICS MARKET FOR DIGESTIVE & GASTROINTESTINAL HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 80 PRECISION BIOTICS MARKET FOR DIGESTIVE & GASTROINTESTINAL HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 81 PRECISION BIOTICS MARKET FOR WOMEN’S HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 82 PRECISION BIOTICS MARKET FOR WOMEN’S HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 83 PRECISION BIOTICS MARKET FOR PEDIATRIC AND INFANT HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 84 PRECISION BIOTICS MARKET FOR PEDIATRIC AND INFANT HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 85 PRECISION BIOTICS MARKET FOR SKIN HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 86 PRECISION BIOTICS MARKET FOR SKIN HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 87 PRECISION BIOTICS MARKET FOR GUT & BRAIN HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 88 PRECISION BIOTICS MARKET FOR GUT & BRAIN HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 89 PRECISION BIOTICS MARKET FOR METABOLIC HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 90 PRECISION BIOTICS MARKET FOR METABOLIC HEALTH, BY REGION, 2026–2031 (USD MILLION) 144 TABLE 91 PRECISION BIOTICS MARKET FOR IMMUNE HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 92 PRECISION BIOTICS MARKET FOR IMMUNE HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 93 PRECISION BIOTICS MARKET FOR ORAL & DENTAL HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 94 PRECISION BIOTICS MARKET FOR ORAL & DENTAL HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 95 PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 96 PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 97 PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (TON)
TABLE 98 PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (TON)
TABLE 99 NORTH AMERICA: PRECISION BIOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 100 NORTH AMERICA: PRECISION BIOTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 101 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 102 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 103 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON)
TABLE 104 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON)
TABLE 105 NORTH AMERICA: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION)
TABLE 106 NORTH AMERICA: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION)
TABLE 107 NORTH AMERICA: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION)
TABLE 108 NORTH AMERICA: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION)
TABLE 109 NORTH AMERICA: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION)
TABLE 110 NORTH AMERICA: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION)
TABLE 111 US: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 112 US: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 113 CANADA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 114 CANADA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 115 EUROPE: PRECISION BIOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 116 EUROPE: PRECISION BIOTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 117 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 118 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 119 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON)
TABLE 120 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON)
TABLE 121 EUROPE: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION) 160 TABLE 122 EUROPE: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION)
TABLE 123 EUROPE: PRECISION BIOTICS MARKET, BY HEALTH & FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION)
TABLE 124 EUROPE: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION)
TABLE 125 EUROPE: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION)
TABLE 126 EUROPE: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION)
TABLE 127 GERMANY: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 128 GERMANY: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 129 UK: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 130 UK: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 131 FRANCE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 132 FRANCE: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 133 ITALY: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 134 ITALY: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 135 SPAIN: PRECISION BIOTICS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 136 SPAIN: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 137 REST OF EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 138 REST OF EUROPE: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 139 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 140 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 141 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 142 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 143 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON)
TABLE 144 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON)
TABLE 145 ASIA PACIFIC: PRECISION BIOTICS MARKET, END-USE INDUSTRY, 2022–2025 (USD MILLION)
TABLE 146 ASIA PACIFIC: PRECISION BIOTICS MARKET, END-USE INDUSTRY, 2026–2031 (USD MILLION)
TABLE 147 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION)
TABLE 148 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION)
TABLE 149 ASIA PACIFIC: PRECISION BIOTICS MARKET, DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION)
TABLE 150 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION)
TABLE 151 CHINA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 152 CHINA: PRECISION BIOTICS MARKET, BY TYPE 2026–2031 (USD MILLION) 175 TABLE 153 INDIA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 154 INDIA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 155 JAPAN: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 156 JAPAN: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 157 AUSTRALIA & NEW ZEALAND: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 158 AUSTRALIA & NEW ZEALAND: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 159 REST OF ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 160 REST OF ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 161 ROW: PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 162 ROW: PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 163 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 164 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 165 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON)
TABLE 166 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON)
TABLE 167 ROW: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION)
TABLE 168 ROW: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION)
TABLE 169 ROW: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION)
TABLE 170 ROW: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION)
TABLE 171 ROW: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION)
TABLE 172 ROW: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION)
TABLE 173 LATIN AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 174 LATIN AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 175 MIDDLE EAST: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 176 MIDDLE EAST: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 177 AFRICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 178 AFRICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 179 OVERVIEW OF STRATEGIES ADOPTED BY KEY PRECISION BIOTICS MANUFACTURER
TABLE 180 PRECISION BIOTICS MARKET: DEGREE OF COMPETITION
TABLE 181 PRECISION BIOTICS MARKET: REGIONAL FOOTPRINT, 2025
TABLE 182 PRECISION BIOTICS MARKET: TYPE FOOTPRINT, 2025
TABLE 183 PRECISION BIOTICS MARKET: FUNCTION FOOTPRINT, 2025
TABLE 184 PRECISION BIOTIC MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025
TABLE 185 PRECISION BIOTIC: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025 205 TABLE 186 PRECISION BIOTICS MARKET: PRODUCT LAUNCHES, NOVEMBER 2021–JUNE 2026
TABLE 187 PRECISION BIOTICS MARKET: DEALS, NOVEMBER 2021–JUNE 2026
TABLE 188 BIOGAIA: COMPANY OVERVIEW
TABLE 189 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 190 BIOGAIA: PRODUCT LAUNCHES
TABLE 191 BIOGAIA: DEALS
TABLE 192 NOVONESIS GROUP: COMPANY OVERVIEW
TABLE 193 NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 194 NOVONESIS GROUP: DEALS
TABLE 195 PROCTER & GAMBLE (P&G).: COMPANY OVERVIEW
TABLE 196 PROCTER & GAMBLE (P&G).: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 197 UNILEVER: COMPANY OVERVIEW
TABLE 198 UNILEVER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 199 UNILEVER: PRODUCT LAUNCHES
TABLE 200 DSM-FIRMENICH GROUP (CULTURELLE): COMPANY OVERVIEW
TABLE 201 DSM-FIRMENICH GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 202 DSM-FIRMENICH GROUP (CULTURELLE): DEALS
TABLE 203 NESTL?: COMPANY OVERVIEW
TABLE 204 NESTL?: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 205 METAGENICS LLC: COMPANY OVERVIEW
TABLE 206 METAGENICS LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 207 METAGENICS LLC: DEALS
TABLE 208 YAKULT HONSHA CO., LTD.: COMPANY OVERVIEW
TABLE 209 YAKULT HONSHA CO., LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 210 YAKULT HONSHA CO., LTD: PRODUCT LAUNCHES
TABLE 211 DANONE: COMPANY OVERVIEW
TABLE 212 DANONE.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 213 DANONE: DEALS
TABLE 214 KANEKA CORPORATION (AB-BIOTICS): COMPANY OVERVIEW
TABLE 215 KANEKA CORPORATION (AB-BIOTICS): PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 216 KANEKA CORPORATION (AB-BIOTICS): PRODUCT LAUNCHES
TABLE 217 SYMRISE GROUP (PROBI): COMPANY OVERVIEW
TABLE 218 SYMRISE GROUP (PROBI): PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 219 JARROW FORMULAS INC: COMPANY OVERVIEW
TABLE 220 JARROW FORMULAS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 221 PENDULUM: COMPANY OVERVIEW
TABLE 222 PENDULUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 223 PENDULUM: PRODUCT LAUNCHES
TABLE 224 THE GOOD BUG: COMPANY OVERVIEW
TABLE 225 THE GOOD BUG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 226 SEED HEALTH INC.: COMPANY OVERVIEW
TABLE 227 SEED HEALTH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 250 TABLE 228 INFINANT HEALTH INC.: COMPANY OVERVIEW
TABLE 229 INFINANT HEALTH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 230 VIOME LIFE SCIENCES, INC.: COMPANY OVERVIEW
TABLE 231 VIOME LIFE SCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 232 VIOME LIFE SCIENCES, INC: PRODUCT LAUNCHES
TABLE 233 BLACKMORES: COMPANY OVERVIEW
TABLE 234 BLACKMORES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 235 LAYER ORIGIN NUTRITION: COMPANY OVERVIEW
TABLE 236 LAYER ORIGIN NUTRITION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 237 RESBIOTIC: COMPANY OVERVIEW
TABLE 238 RESBIOTIC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 239 RESTBIOTIC: PRODUCT LAUNCHES
TABLE 240 KEY DATA FROM PRIMARY SOURCES
TABLE 241 MARKETS ADJACENT TO PRECISION BIOTICS MARKET
TABLE 242 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022–2025 (USD MILLION)
TABLE 243 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026–2031 (USD MILLION)
TABLE 244 PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 245 PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 1 INCLUSIONS AND EXCLUSIONS
TABLE 2 USD EXCHANGE RATES, 2021–2025
TABLE 3 INTERCONNECTED MARKETS
TABLE 4 PRECISION BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5 PRECISION BIOTICS MARKET: SUPPLY CHAIN (ECOSYSTEM)
TABLE 6 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON)
TABLE 7 AVERAGE SELLING PRICE (ASP) TREND BY TYPE, 2022–2025 (USD/TONS)
TABLE 8 TOP IMPORTERS OF PRECISION BIOTICS, 2022–2025 (USD)
TABLE 9 TOP EXPORTERS OF PRECISION BIOTICS, 2022–2025 (USD)
TABLE 10 PRECISION BIOTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 11 PATENTS PERTAINING TO PRECISION BIOTICS MARKET, 2021–2026
TABLE 12 TOP USE CASES AND MARKET POTENTIAL
TABLE 13 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
TABLE 14 PRECISION BIOTICS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
TABLE 15 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 INDUSTRY STANDARDS IN PRECISION BIOTICS MARKET
TABLE 22 LABELING REQUIREMENTS AND CLAIMS IN PRECISION BIOTICS MARKET
TABLE 23 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PRECISION BIOTICS MARKET
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES
TABLE 25 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
TABLE 26 UNMET NEEDS IN PRECISION BIOTICS MARKET, BY APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
TABLE 27 COST DYNAMICS IN PRECISION MARKET
TABLE 28 MARGIN OPPORTUNITIES IN PRECISION BIOTICS MARKET, BY TYPE
TABLE 29 PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 30 PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 31 PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON)
TABLE 32 PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON)
TABLE 33 PRECISION PROBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 34 PRECISION PROBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION) 109 TABLE 35 PRECISION PROBIOTICS MARKET, BY REGION, 2022–2025 (TONS)
TABLE 36 PRECISION PROBIOTICS MARKET, BY REGION, 2026–2031 (TONS)
TABLE 37 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 38 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 39 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2022–2025 (TONS)
TABLE 40 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2026–2031 (TONS)
TABLE 41 SYNBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 42 SYNBIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 43 SYNBIOTICS MARKET, BY REGION, 2022–2025 (TONS)
TABLE 44 SYNBIOTICS MARKET, BY REGION, 2026–2031 (TONS)
TABLE 45 POSTBIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 46 POSTBOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 47 POSTBIOTICS MARKET, BY REGION, 2022–2025 (TONS)
TABLE 48 POSTBOTICS MARKET, BY REGION, 2026–2031 (TONS)
TABLE 49 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION)
TABLE 50 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION)
TABLE 51 PRECISION BIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2022–2025 (USD MILLION)
TABLE 52 PRECISION BIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2026–2031 (USD MILLION)
TABLE 53 PRECISION BIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2022–2025 (USD MILLION)
TABLE 54 PRECISION BIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2026–2031 (USD MILLION)
TABLE 55 PRECISION BIOTICS MARKET IN PET SUPPLEMENTS, BY REGION, 2022–2025 (USD MILLION)
TABLE 56 PRECISION BIOTICS MARKET IN PET SUPPLEMENTS, BY REGION, 2026–2031 (USD MILLION)
TABLE 57 PRECISION BIOTICS MARKET IN PHARMACEUTICALS (OTC), BY REGION, 2022–2025 (USD MILLION)
TABLE 58 PRECISION BIOTICS MARKET IN PHARMACEUTICALS (OTC), BY REGION, 2026–2031 (USD MILLION)
TABLE 59 PRECISION BIOTICS MARKET IN INFANT FORMULA, BY REGION, 2022–2025 (USD MILLION)
TABLE 60 PRECISION BIOTICS MARKET IN INFANT FORMULA, BY REGION, 2026–2031 (USD MILLION)
TABLE 61 PRECISION BIOTICS MARKET IN COSMETICS, BY REGION, 2022–2025 (USD MILLION)
TABLE 62 PRECISION BIOTICS MARKET IN COSMETICS, BY REGION, 2026–2031 (USD MILLION)
TABLE 63 PRECISION BIOTICS MARKET IN ANIMAL FEED, BY REGION, 2022–2025 (USD MILLION)
TABLE 64 PRECISION BIOTICS MARKET IN ANIMAL FEED, BY REGION, 2026–2031 (USD MILLION)
TABLE 65 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 128 TABLE 66 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION)
TABLE 67 PRECISION BIOTICS MARKET FROM PHARMACIES, BY REGION, 2022–2025 (USD MILLION)
TABLE 68 PRECISION BIOTICS MARKET FROM PHARMACIES, BY REGION, 2026–2031 (USD MILLION)
TABLE 69 PRECISION BIOTICS MARKET FROM RETAIL, BY REGION, 2022–2025 (USD MILLION)
TABLE 70 PRECISION BIOTICS MARKET FROM RETAIL, BY REGION, 2026–2031 (USD MILLION)
TABLE 71 PRECISION BIOTICS MARKET FROM SPECIALTY STORES, BY REGION, 2022–2025 (USD MILLION)
TABLE 72 SPECIALTY STORES: PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 73 PRECISION BIOTICS MARKET FROM E-COMMERCE, BY REGION, 2022–2025 (USD MILLION)
TABLE 74 PRECISION BIOTICS MARKET FROM E-COMMERCE, BY REGION, 2026–2031 (USD MILLION)
TABLE 75 PRECISION BIOTICS MARKET FROM DTC SUBSCRIPTION PLATFORMS, BY REGION, 2022–2025 (USD MILLION)
TABLE 76 PRECISION BIOTICS MARKET FROM DTC SUBSCRIPTION PLATFORMS, BY REGION, 2026–2031 (USD MILLION)
TABLE 77 PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION)
TABLE 78 PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION)
TABLE 79 PRECISION BIOTICS MARKET FOR DIGESTIVE & GASTROINTESTINAL HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 80 PRECISION BIOTICS MARKET FOR DIGESTIVE & GASTROINTESTINAL HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 81 PRECISION BIOTICS MARKET FOR WOMEN’S HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 82 PRECISION BIOTICS MARKET FOR WOMEN’S HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 83 PRECISION BIOTICS MARKET FOR PEDIATRIC AND INFANT HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 84 PRECISION BIOTICS MARKET FOR PEDIATRIC AND INFANT HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 85 PRECISION BIOTICS MARKET FOR SKIN HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 86 PRECISION BIOTICS MARKET FOR SKIN HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 87 PRECISION BIOTICS MARKET FOR GUT & BRAIN HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 88 PRECISION BIOTICS MARKET FOR GUT & BRAIN HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 89 PRECISION BIOTICS MARKET FOR METABOLIC HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 90 PRECISION BIOTICS MARKET FOR METABOLIC HEALTH, BY REGION, 2026–2031 (USD MILLION) 144 TABLE 91 PRECISION BIOTICS MARKET FOR IMMUNE HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 92 PRECISION BIOTICS MARKET FOR IMMUNE HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 93 PRECISION BIOTICS MARKET FOR ORAL & DENTAL HEALTH, BY REGION, 2022–2025 (USD MILLION)
TABLE 94 PRECISION BIOTICS MARKET FOR ORAL & DENTAL HEALTH, BY REGION, 2026–2031 (USD MILLION)
TABLE 95 PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 96 PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 97 PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (TON)
TABLE 98 PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (TON)
TABLE 99 NORTH AMERICA: PRECISION BIOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 100 NORTH AMERICA: PRECISION BIOTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 101 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 102 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 103 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON)
TABLE 104 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON)
TABLE 105 NORTH AMERICA: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION)
TABLE 106 NORTH AMERICA: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION)
TABLE 107 NORTH AMERICA: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION)
TABLE 108 NORTH AMERICA: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION)
TABLE 109 NORTH AMERICA: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION)
TABLE 110 NORTH AMERICA: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION)
TABLE 111 US: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 112 US: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 113 CANADA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 114 CANADA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 115 EUROPE: PRECISION BIOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 116 EUROPE: PRECISION BIOTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 117 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 118 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 119 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON)
TABLE 120 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON)
TABLE 121 EUROPE: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION) 160 TABLE 122 EUROPE: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION)
TABLE 123 EUROPE: PRECISION BIOTICS MARKET, BY HEALTH & FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION)
TABLE 124 EUROPE: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION)
TABLE 125 EUROPE: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION)
TABLE 126 EUROPE: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION)
TABLE 127 GERMANY: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 128 GERMANY: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 129 UK: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 130 UK: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 131 FRANCE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 132 FRANCE: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 133 ITALY: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 134 ITALY: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 135 SPAIN: PRECISION BIOTICS MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 136 SPAIN: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 137 REST OF EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 138 REST OF EUROPE: PRECISION BIOTICS MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 139 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 140 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 141 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 142 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 143 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON)
TABLE 144 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON)
TABLE 145 ASIA PACIFIC: PRECISION BIOTICS MARKET, END-USE INDUSTRY, 2022–2025 (USD MILLION)
TABLE 146 ASIA PACIFIC: PRECISION BIOTICS MARKET, END-USE INDUSTRY, 2026–2031 (USD MILLION)
TABLE 147 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION)
TABLE 148 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION)
TABLE 149 ASIA PACIFIC: PRECISION BIOTICS MARKET, DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION)
TABLE 150 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION)
TABLE 151 CHINA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 152 CHINA: PRECISION BIOTICS MARKET, BY TYPE 2026–2031 (USD MILLION) 175 TABLE 153 INDIA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 154 INDIA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 155 JAPAN: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 156 JAPAN: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 157 AUSTRALIA & NEW ZEALAND: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 158 AUSTRALIA & NEW ZEALAND: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 159 REST OF ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 160 REST OF ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 161 ROW: PRECISION BIOTICS MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 162 ROW: PRECISION BIOTICS MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 163 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 164 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 165 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (TON)
TABLE 166 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (TON)
TABLE 167 ROW: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022–2025 (USD MILLION)
TABLE 168 ROW: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION)
TABLE 169 ROW: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022–2025 (USD MILLION)
TABLE 170 ROW: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026–2031 (USD MILLION)
TABLE 171 ROW: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION)
TABLE 172 ROW: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION)
TABLE 173 LATIN AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 174 LATIN AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 175 MIDDLE EAST: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 176 MIDDLE EAST: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 177 AFRICA: PRECISION BIOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 178 AFRICA: PRECISION BIOTICS MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 179 OVERVIEW OF STRATEGIES ADOPTED BY KEY PRECISION BIOTICS MANUFACTURER
TABLE 180 PRECISION BIOTICS MARKET: DEGREE OF COMPETITION
TABLE 181 PRECISION BIOTICS MARKET: REGIONAL FOOTPRINT, 2025
TABLE 182 PRECISION BIOTICS MARKET: TYPE FOOTPRINT, 2025
TABLE 183 PRECISION BIOTICS MARKET: FUNCTION FOOTPRINT, 2025
TABLE 184 PRECISION BIOTIC MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025
TABLE 185 PRECISION BIOTIC: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025 205 TABLE 186 PRECISION BIOTICS MARKET: PRODUCT LAUNCHES, NOVEMBER 2021–JUNE 2026
TABLE 187 PRECISION BIOTICS MARKET: DEALS, NOVEMBER 2021–JUNE 2026
TABLE 188 BIOGAIA: COMPANY OVERVIEW
TABLE 189 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 190 BIOGAIA: PRODUCT LAUNCHES
TABLE 191 BIOGAIA: DEALS
TABLE 192 NOVONESIS GROUP: COMPANY OVERVIEW
TABLE 193 NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 194 NOVONESIS GROUP: DEALS
TABLE 195 PROCTER & GAMBLE (P&G).: COMPANY OVERVIEW
TABLE 196 PROCTER & GAMBLE (P&G).: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 197 UNILEVER: COMPANY OVERVIEW
TABLE 198 UNILEVER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 199 UNILEVER: PRODUCT LAUNCHES
TABLE 200 DSM-FIRMENICH GROUP (CULTURELLE): COMPANY OVERVIEW
TABLE 201 DSM-FIRMENICH GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 202 DSM-FIRMENICH GROUP (CULTURELLE): DEALS
TABLE 203 NESTL?: COMPANY OVERVIEW
TABLE 204 NESTL?: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 205 METAGENICS LLC: COMPANY OVERVIEW
TABLE 206 METAGENICS LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 207 METAGENICS LLC: DEALS
TABLE 208 YAKULT HONSHA CO., LTD.: COMPANY OVERVIEW
TABLE 209 YAKULT HONSHA CO., LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 210 YAKULT HONSHA CO., LTD: PRODUCT LAUNCHES
TABLE 211 DANONE: COMPANY OVERVIEW
TABLE 212 DANONE.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 213 DANONE: DEALS
TABLE 214 KANEKA CORPORATION (AB-BIOTICS): COMPANY OVERVIEW
TABLE 215 KANEKA CORPORATION (AB-BIOTICS): PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 216 KANEKA CORPORATION (AB-BIOTICS): PRODUCT LAUNCHES
TABLE 217 SYMRISE GROUP (PROBI): COMPANY OVERVIEW
TABLE 218 SYMRISE GROUP (PROBI): PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 219 JARROW FORMULAS INC: COMPANY OVERVIEW
TABLE 220 JARROW FORMULAS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 221 PENDULUM: COMPANY OVERVIEW
TABLE 222 PENDULUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 223 PENDULUM: PRODUCT LAUNCHES
TABLE 224 THE GOOD BUG: COMPANY OVERVIEW
TABLE 225 THE GOOD BUG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 226 SEED HEALTH INC.: COMPANY OVERVIEW
TABLE 227 SEED HEALTH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 250 TABLE 228 INFINANT HEALTH INC.: COMPANY OVERVIEW
TABLE 229 INFINANT HEALTH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 230 VIOME LIFE SCIENCES, INC.: COMPANY OVERVIEW
TABLE 231 VIOME LIFE SCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 232 VIOME LIFE SCIENCES, INC: PRODUCT LAUNCHES
TABLE 233 BLACKMORES: COMPANY OVERVIEW
TABLE 234 BLACKMORES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 235 LAYER ORIGIN NUTRITION: COMPANY OVERVIEW
TABLE 236 LAYER ORIGIN NUTRITION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 237 RESBIOTIC: COMPANY OVERVIEW
TABLE 238 RESBIOTIC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 239 RESTBIOTIC: PRODUCT LAUNCHES
TABLE 240 KEY DATA FROM PRIMARY SOURCES
TABLE 241 MARKETS ADJACENT TO PRECISION BIOTICS MARKET
TABLE 242 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022–2025 (USD MILLION)
TABLE 243 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026–2031 (USD MILLION)
TABLE 244 PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 245 PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
LIST OF FIGURES
FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE
FIGURE 2 STUDY YEARS CONSIDERED
FIGURE 3 MARKET SCENARIO
FIGURE 4 PRECISION BIOTICS MARKET, 2022–2031 (USD BILLION)
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PRECISION BIOTICS MARKET, 2022–JUNE 2026
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PRECISION BIOTICS MARKET
FIGURE 7 PRECISION BIOTICS MARKET: HIGH-GROWTH SEGMENTS, 2026–2031
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 9 INCREASING CONSUMER FOCUS ON GUT HEALTH AND PREVENTIVE HEALTHCARE TO ACCELERATE GROWTH OPPORTUNITIES IN PRECISION BIOTICS MARKET
FIGURE 10 PRECISION PROBIOTICS TYPE SEGMENT AND NORTH AMERICA REGION TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
FIGURE 11 PRECISION PROBIOTICS TYPE SEGMENT TO LEAD MARKET IN 2026
FIGURE 12 PHARMACIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 13 DIGESTIVE & GASTROINTESTINAL HEALTH SEGMENT TO DOMINATE MARKET IN 2026
FIGURE 14 DIETARY SUPPLEMENTS END-USE INDUSTRY SEGMENT TO DOMINATE MARKET IN 2026
FIGURE 15 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 16 PRECISION BIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17 PRECISION BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 18 NATIONAL HEALTH EXPENDITURE PER CAPITA IN US FROM 2020 TO 2024
FIGURE 19 PRECISION BIOTIC MARKET: VALUE CHAIN ANALYSIS
FIGURE 20 PRECISION BIOTICS MARKET ECOSYSTEM MAP
FIGURE 21 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON)
FIGURE 22 IMPORT OF HS CODE 300249, BY KEY COUNTRY, 2022–2025 (USD)
FIGURE 23 EXPORT OF HS CODE 300249, BY KEY COUNTRY, 2022–2025 (USD)
FIGURE 24 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES
FIGURE 25 INVESTMENT AND FUNDING SCENARIO
FIGURE 26 NUMBER OF PATENTS GRANTED BETWEEN 2016 AND 2026
FIGURE 27 FUTURE APPLICATIONS
FIGURE 28 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
FIGURE 29 PRECISION BIOTICS MARKET DECISION-MAKING FACTORS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES
FIGURE 31 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
FIGURE 32 ADOPTION BARRIERS AND INTERNAL CHALLENGES
FIGURE 33 PRECISION BIOTICS MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 34 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026 VS. 2031 (USD MILLION)
FIGURE 35 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026 VS. 2031 (USD MILLION)
FIGURE 36 PRECISION BIOTICS MARKET, BY HEALTH & FUNCTIONAL POSITIONING, 2026 VS. 2031 (USD MILLION)
FIGURE 37 PRECISION BIOTICS MARKET, BY KEY COUNTRY, 2026–2031 (USD MILLION)
FIGURE 38 NORTH AMERICA: PRECISION BIOTICS MARKET SNAPSHOT
FIGURE 39 ASIA PACIFIC: PRECISION BIOTICS MARKET SNAPSHOT
FIGURE 40 REVENUE ANALYSIS FOR KEY COMPANIES, 2023–2025 (USD BILLION)
FIGURE 41 SHARE OF LEADING COMPANIES IN PRECISION BIOTICS MARKET, 2025
FIGURE 42 COMPANY VALUATION OF PRECISION BIOTICS MANUFACTURERS, 2025
FIGURE 43 EV/EBITDA OF KEY COMPANIES, 2025
FIGURE 44 BRAND/PRODUCT/SERVICE ANALYSIS, BY KEY PLAYERS OF PRECISION BIOTICS MARKET
FIGURE 45 PRECISION BIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 46 PRECISION BIOTICS MARKET: COMPANY FOOTPRINT, 2025
FIGURE 47 PRECISION BIOTIC MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 48 BIOGAIA: COMPANY SNAPSHOT
FIGURE 49 NOVONESIS GROUP: COMPANY SNAPSHOT
FIGURE 50 PROCTER & GAMBLE (P&G): COMPANY SNAPSHOTS
FIGURE 51 UNILEVER: COMPANY SNAPSHOTS
FIGURE 52 DSM-FIRMENICH GROUP (CULTURELLE): COMPANY SNAPSHOT
FIGURE 53 NESTL?: COMPANY SNAPSHOT
FIGURE 54 YAKULT HONSHA CO., LTD: COMPANY SNAPSHOT
FIGURE 55 DANONE: COMPANY SNAPSHOT
FIGURE 56 AB-BIOTICS (SUBSIDIARY OF KANEKA COMPANY): COMPANY SNAPSHOT
FIGURE 57 SYMRISE GROUP (PROBI): SNAPSHOT
FIGURE 58 PRECISION BIOTICS MARKET: RESEARCH DESIGN
FIGURE 59 KEY DATA FROM SECONDARY SOURCES
FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 61 KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 62 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 63 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
FIGURE 64 PRECISION BIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 65 DATA TRIANGULATION
FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE
FIGURE 2 STUDY YEARS CONSIDERED
FIGURE 3 MARKET SCENARIO
FIGURE 4 PRECISION BIOTICS MARKET, 2022–2031 (USD BILLION)
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PRECISION BIOTICS MARKET, 2022–JUNE 2026
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PRECISION BIOTICS MARKET
FIGURE 7 PRECISION BIOTICS MARKET: HIGH-GROWTH SEGMENTS, 2026–2031
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 9 INCREASING CONSUMER FOCUS ON GUT HEALTH AND PREVENTIVE HEALTHCARE TO ACCELERATE GROWTH OPPORTUNITIES IN PRECISION BIOTICS MARKET
FIGURE 10 PRECISION PROBIOTICS TYPE SEGMENT AND NORTH AMERICA REGION TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
FIGURE 11 PRECISION PROBIOTICS TYPE SEGMENT TO LEAD MARKET IN 2026
FIGURE 12 PHARMACIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 13 DIGESTIVE & GASTROINTESTINAL HEALTH SEGMENT TO DOMINATE MARKET IN 2026
FIGURE 14 DIETARY SUPPLEMENTS END-USE INDUSTRY SEGMENT TO DOMINATE MARKET IN 2026
FIGURE 15 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 16 PRECISION BIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17 PRECISION BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 18 NATIONAL HEALTH EXPENDITURE PER CAPITA IN US FROM 2020 TO 2024
FIGURE 19 PRECISION BIOTIC MARKET: VALUE CHAIN ANALYSIS
FIGURE 20 PRECISION BIOTICS MARKET ECOSYSTEM MAP
FIGURE 21 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON)
FIGURE 22 IMPORT OF HS CODE 300249, BY KEY COUNTRY, 2022–2025 (USD)
FIGURE 23 EXPORT OF HS CODE 300249, BY KEY COUNTRY, 2022–2025 (USD)
FIGURE 24 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES
FIGURE 25 INVESTMENT AND FUNDING SCENARIO
FIGURE 26 NUMBER OF PATENTS GRANTED BETWEEN 2016 AND 2026
FIGURE 27 FUTURE APPLICATIONS
FIGURE 28 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
FIGURE 29 PRECISION BIOTICS MARKET DECISION-MAKING FACTORS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES
FIGURE 31 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
FIGURE 32 ADOPTION BARRIERS AND INTERNAL CHALLENGES
FIGURE 33 PRECISION BIOTICS MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 34 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026 VS. 2031 (USD MILLION)
FIGURE 35 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026 VS. 2031 (USD MILLION)
FIGURE 36 PRECISION BIOTICS MARKET, BY HEALTH & FUNCTIONAL POSITIONING, 2026 VS. 2031 (USD MILLION)
FIGURE 37 PRECISION BIOTICS MARKET, BY KEY COUNTRY, 2026–2031 (USD MILLION)
FIGURE 38 NORTH AMERICA: PRECISION BIOTICS MARKET SNAPSHOT
FIGURE 39 ASIA PACIFIC: PRECISION BIOTICS MARKET SNAPSHOT
FIGURE 40 REVENUE ANALYSIS FOR KEY COMPANIES, 2023–2025 (USD BILLION)
FIGURE 41 SHARE OF LEADING COMPANIES IN PRECISION BIOTICS MARKET, 2025
FIGURE 42 COMPANY VALUATION OF PRECISION BIOTICS MANUFACTURERS, 2025
FIGURE 43 EV/EBITDA OF KEY COMPANIES, 2025
FIGURE 44 BRAND/PRODUCT/SERVICE ANALYSIS, BY KEY PLAYERS OF PRECISION BIOTICS MARKET
FIGURE 45 PRECISION BIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 46 PRECISION BIOTICS MARKET: COMPANY FOOTPRINT, 2025
FIGURE 47 PRECISION BIOTIC MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 48 BIOGAIA: COMPANY SNAPSHOT
FIGURE 49 NOVONESIS GROUP: COMPANY SNAPSHOT
FIGURE 50 PROCTER & GAMBLE (P&G): COMPANY SNAPSHOTS
FIGURE 51 UNILEVER: COMPANY SNAPSHOTS
FIGURE 52 DSM-FIRMENICH GROUP (CULTURELLE): COMPANY SNAPSHOT
FIGURE 53 NESTL?: COMPANY SNAPSHOT
FIGURE 54 YAKULT HONSHA CO., LTD: COMPANY SNAPSHOT
FIGURE 55 DANONE: COMPANY SNAPSHOT
FIGURE 56 AB-BIOTICS (SUBSIDIARY OF KANEKA COMPANY): COMPANY SNAPSHOT
FIGURE 57 SYMRISE GROUP (PROBI): SNAPSHOT
FIGURE 58 PRECISION BIOTICS MARKET: RESEARCH DESIGN
FIGURE 59 KEY DATA FROM SECONDARY SOURCES
FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 61 KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 62 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 63 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
FIGURE 64 PRECISION BIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 65 DATA TRIANGULATION
